1.
Papp K, Reich K, Blauvelt A, Thaci D, Sinclair R, Tyring SK, Cichanowitz N, Green S, Li Q, La Rosa C. Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. J of Skin [Internet]. 2018 Feb. 23 [cited 2024 Jul. 3];2(S1):S4. Available from: https://jofskin.org/33014/index.php/skin/article/view/252